Good find by rndtbl over on Investor Village.
Constellation Pharma up 152% on positive CPI-0610 data
https://seekingalpha.com/news/3515394-constellation-pharma-152-percent-positive-cpiminus-0610-data
This abstract to be presented at the December ASH meeting.
Zenith isn't in the myelofibrosis arena and Constellation isn't in the breast/prostate cancer arena. So no near term competition. Is Constellation the most advanced BET inhibitor rival to Zenith? Here's Constellation's recent Corporate Presentation.
BDAZ